Solid Biosciences to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Solid Biosciences to Present at the Jefferies London Healthcare Conference
Solid Biosciences Inc. (NASDAQ: SLDB) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $12.00. They now have an "overweight" rating on the stock.
Solid Biosciences Inc. (NASDAQ: SLDB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $15.00 price target on the stock.
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate [Yahoo! Finance]